alaska capsule endoscopy payer guidelines - … capsule endoscopy payer guidelines - cpt 91110 mac:...

53
Payer / Policy Name Link to Policy Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy) Medicare Part B Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy Capsule Endoscopy Celiac disease Suspected Crohn's disease Suspected small intestinal bleeding Premera BCBS Obscure GI bleed OGIB: Prior inconclusive upper AND lower gastrointestinal endoscopic studies Suspected Crohn's disease https://www.premera.com/stellent/groups/public/documents/medicalpolicy/cmi_003621.htm Cigna Obscure GI bleed Capsule Endoscopy Suspected Crohn's disease Suspected small bowel tumor Celiac disease Humana Obscure GI bleed Unlisted Capsule Endoscopy Suspected Crohn's or Celiac disease Polyposis syndromes Suspected small intestinal tumors United Healthcare GI blood loss and/or iron-deficiency anemia Suspected or known Crohn's disease Celiac disease Suspected small bowel tumor Celiac disease: Prior serology or GI endoscopy are not diagnostic Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor April 2012 https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en- US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization. Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood. "The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof. OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C GI blood loss and/or iron deficiency anemia:Upper endoscopy and colonoscopy are negative for source of bleeding 152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09 Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the test Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz- Jeghers syndrome http://www.aetna.com/cpb/medical/data/500_599/0588.html All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive 152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0 http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf Wireless Capsule Endoscopy as a Diagnostic Technique in the Disorders of the Small Bowel, Esophagus and Colon Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome Crohn's: Without evidence of disease on conventional diagnostics tests such as SBFT and upper and lower endoscopy 211.2, 555.0, 555.1, 555.2, 555.9, 578.0, 578.1. 578.9, 759.6 209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1- 558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1 Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source ALASKA Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims will be manually reviewed.

Upload: vutu

Post on 04-May-2018

254 views

Category:

Documents


4 download

TRANSCRIPT

Page 1: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Premera BCBS Obscure GI bleed OGIB: Prior inconclusive upper AND lower gastrointestinal endoscopic studiesSuspected Crohn's disease

https://www.premera.com/stellent/groups/public/documents/medicalpolicy/cmi_003621.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.aetna.com/cpb/medical/data/500_599/0588.html

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Wireless Capsule Endoscopy as a

Diagnostic Technique in the Disorders of the Small

Bowel, Esophagus and Colon

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Without evidence of disease on conventional diagnostics tests such as SBFT and upper and lower endoscopy

211.2, 555.0, 555.1, 555.2, 555.9, 578.0, 578.1. 578.9, 759.6

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

ALASKA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Page 2: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedCrohn's diseaseSuspected small intestinal tumors

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS AL Recurrent, obscure GI bleed UnlistedSuspected Crohn's diseaseKnown Crohn's disease

https://www.bcbsal.org/providers/policies/final/017.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

ALABAMA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Cahaba Government Benefit

Administrators

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the test

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30045&ContrId=213&ver=20&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Alabama&CptHcpcsCode=91110&KeyWordLookUp=Title&KeyWordSearchType=And&bc=gAAAABAAAAAA&

152.0-152.9, 197.4, 211.2, 211.3, 230.7, 235.2, 259.2, 280.0, 280.9, 285.1, 555.0, 555.2, 555.9, 557.0-557.9, 558.1, 558.2, 558.41, 558.42, 558.9, 562.02-562.03, 569.84, 569.86, 578.1-578.9, 579.0, 579.1, 579.8, 579.9, 792.1, V10.09

OGIB: Documented GI blood loss and anemia secondary to bleeding. Site not previously identified by upper GI endoscopy, colonoscopy, push enteroscopy or radiological procedureCrohn's: Suspected but undiagnosed Crohn's or when necessary to determine whether there is small bowel involvement** It is expected that this test will be performed only once during any episode of illness

Medicine: Wireless Capsule Imaging

Suspected or refractory malabsorptive syndromes (eg, Celiac disease)

Crohn's: Without evidence of disease on conventional diagnostic tests such as upper GI, EGD, or colonoscopy

Wireless Capsule Endoscopy

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: Must have negative diagnostic work-up (e.g., upper GI, EGD, or colonoscopy)

Page 3: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedSuspected Angiodysplasias of the GI tractKnown Crohn's disease

Capsule Endoscopy

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS AR Suspected Crohn's disease UnlistedObscure GI bleedingIron deficiency anemia

http://www.arkansasbluecross.com/members/report.aspx?policyNumber=2002008

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and/or upper and lower endoscopyOGIB: Not found on upper and lower GI endoscopic studies, although bleeding has been noted in the stool by direct observation or immunohistochemical testing

Iron deficiency anemia: Not diagnosed by upper and lower GI endoscopy, and bleeding has not been detected by direct observation from the colon or rectum, or by immunohistochemical testing, and yet the cause is of suspected small bowel originGI polyposis syndromes: Surveillance is allowed no more frequently than annually in patients in whom polyps are detected in the small bowel distal to the first portion of the duodenum, and no more frequently than biennially in patients in whom polyps are not detected

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Wireless Capsule Endoscopy, Small Bowel

StudyHereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

ARKANSAS

Capsule Endoscopy Payer Guidelines - CPT 91110

Carrier: Pinnacle Business Solutions, Inc.

OGIB: Not previously identified by upper GI endoscopy, colonoscopy, push endoscopy or other radiologic procedure

280.9, 555.0-555.9, 578.1, 578.9, 792.1

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=13429&ContrId=5&ver=12&ContrVer=1&CntrctrSelected=5*1&Cntrctr=5&name=Pinnacle+Business+Solutions%2c+Inc.+-+Arkansas+(00520%2c+Carrier)&LCntrctr=219*1%7c58*1%7c5*1%7c3*1&bc=AgACAAIAAAAA&

Page 4: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS AZ Obscure gastrointestinal bleeding UnlistedSuspected Crohn's disease

https://secure.azblue.com/pdf/medpol/o272.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

HealthNet Obscure GI bleedSmall bowel neoplasmSuspected Crohn's disease

https://www.healthnet.com/static/general/unprotected/pdfs/national/policies/Wireless_Capsule_Endoscopy_Jul_11.pdf

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: Iron deficiency anemia, postive fecal occult blood test, or visible bleeding with no source found on original endoscopy, hematocrit < 34, failure of previous diagnostics to diagnose source of GI bleeding and GI bleeding is thought to be in the small intestine

152.0-152.9, 197.4, 211.1, 230.7, 280.0, 280.9, 555.0-555.9, 558.1, 558.2, 558.9, 560.02, 560.03, 569.85, 569.86, 571.2, 571.5, 578.1, 578.9, 792.1

Small Bowel Neoplasm: Diagnosis not previously confirmed by upper GI, colonoscopy, push enteroscopy, nuclear imaging or radiological procedures. Patient must be symptomatic for neoplasm (e.g. GI bleeding)

OGIB: Bleeding of unknown origin that persists or recurs after a negative initial upperand lower endoscopy (may be visible or occult)Crohn's: Negative upper and lower endoscopy and documentation of ANY of the following: abdominal pain, persistent; bleeding; diarrhea; negative stool cultures; weight loss

Endoscopy by Video Capsule Hereditary GI polyposis syndromes including familial

adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

No published LCD for capsule endoscopy. Claims will be manually reviewed.

ARIZONA

Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

MAC: Noridian Administrative Services

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Wireless Capsule Endoscopy

Crohn's: Patient has diarrhea, GI bleeding, abdominal pain, weight loss, negative stool cultures and negative upper and lower endoscopy

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

Page 5: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part BMAC: Palmetto GBA

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

Anthem Blue Cross Obscure GI bleeding

Suspected Crohn's disease

Diagnostic re-evaluation of Crohn's disease

Suspected small intestinal tumors

Lynch syndrome or polyposis syndromes

Refractory undiagnosed malabsorptive syndromes

Iron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

Cigna Obscure GI bleed

Capsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumor

Celiac disease

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

HealthNet Obscure GI bleed

Small bowel neoplasm

Suspected Crohn's disease

https://www.healthnet.com/static/general/unprotected/pdfs/national/policies/Wireless_Capsule_Endoscopy_Jul_11.pdf

United Healthcare GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnostic

Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

CALIFORNIA

Capsule Endoscopy Payer Guidelines - CPT 91110

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Crohn's: Patient has diarrhea, GI bleeding, abdominal pain, weight loss, negative

stool cultures and negative upper and lower endoscopy.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of

the test

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-

US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Wireless Capsule

Endoscopy

Lynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy

are negative for source of bleeding

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 759.6, 578.0, 578.1,

578.9, 579.0, 792.1, V84.09

Wireless Capsule

Endoscopy

152.0-152.9, 211.2, 235.2,

280.0, 280.8, 280.9, 281.9,

285.9, 555.0-555.9, 558.9,

578.1-578.9, 579.0

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Wireless Capsule

Endoscopy for

Esophageal and Small

Bowel Imaging and the

Patency Capsule

OGIB: Upper and lower endoscopy excluded a source of bleeding in the upper GI

tract or colon

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no

suspected or confirmed GI obstruction, stricture, or fistulae

OGIB: Iron deficiency anemia, postive fecal occult blood test, or visible bleeding

with no source found on original endoscopy, hematocrit < 34, failure of previous

diagnostics to diagnose source of GI bleeding and GI bleeding is thought to be in

the small intestine

Small Bowel Neoplasm: Diagnosis not previously confirmed by upper GI,

colonoscopy, push enteroscopy, nuclear imaging or radiological procedures. Patient

must be symptomatic for neoplasm (e.g. GI bleeding)

152.0-152.9, 197.4, 211.1,

230.7, 280.0, 280.9, 555.0-

555.9, 558.1, 558.2, 558.9,

560.02, 560.03, 569.85,

569.86, 571.2, 571.5, 578.1,

578.9, 792.1

http://www.anthem.com/ca/medicalpolicies/policies/mp_pw_a050543.htm

All diagnoses: Standard endoscopic and imaginag evaluations (i.e., upper and

lower endoscopy) are inconclusive

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Crohn's re-evaluation: Symptomatic after appropriate treatment has occurred and

there is no suspected or confirmed GI obstruction, stricture or fistulae

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g.

suspected celiac disease with prior negative biopsy)

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with

urinalysis and examination of abdomen and pelvis) has excluded a source of

anemia from the GU region, upper GI tract and colon

152.0-152.9, 153.0-153.9,

154.0-154.1, 154.8, 209.00-

209.03, 211.2, 235.2, 280.0-

280.9, 555.0-555.9, 578.0-

578.9, 579.0-579.9, V12.72,

V71.1, V71.89

Page 6: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingCeliac diseaseSuspected or known Crohn's diseaseColitis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

Wireless Capsule Endoscopy

OGIB: Source of bleeding not previously identified by upper GI and colonoscopy and any of the following: push enteroscopy, nuclear imaging or radiological procedures; medical record must indicate if anemia is present

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evalution (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=26816&ContrId=157&ver=29&ContrVer=1&Date=04%2f15%2f2012&DocID=L26816&bc=iAAAAAgAAAAA&

COLORADO

Capsule Endoscopy Payer Guidelines - CPT 91110

014.80-014.86, 152.0-152.3, 152.8, 152.9, 197.4, 211.2, 230.7, 251.5, 280.9, 447.6, 537.83-537.84, 555.0-555.2, 555.9, 557.1, 558.1, 562.02-562.03, 569.85-569.86, 578.1, 579.0, 792.1

MAC: Trailblazer Health Enterprises, LLC

Page 7: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

Oxford Health Plans GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac Disease: Prior serology or GI endoscopy are not diagnosticSmall Bowel Tumor: Imaging studies or GI endoscopy failed to confirm tumor

April 2012

CONNECTCUIT

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.MAC: National Government Services

http://www.aetna.com/cpb/medical/data/500_599/0588.html

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulae

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 578.0, 578.1, 578.9, 579.0, 759.6, 792.1, V84.09

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel

Crohn's: Imaging studies and/or upper or lower GI endoscopic examination fail to reveal the location or extent of the pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

OGIB: After appropriate evalution (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

GI blood loss/Iron-deficiency anemia: Other diagnostic methods (upper endoscopy and colonoscopy) failed to identify source of bleeding

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Wireless Capsule Endoscopy

Crohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

https://www.oxhp.com/secure/policy/wireless_capsule_endoscopy_212.html

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Page 8: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS DE Angiodysplasias of the GI tract

Suspected Crohn's diseaseOccult GI bleedingPeutz-Jeghers syndrome Suspected or refractory malabsorptive syndromesSuspected small bowel tumors

https://www.bcbsde.com/ProviderPolicies/public_site/7.01.76_Wireless_Capsule_Endoscopy.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Wireless Capsule Endoscopy

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the test

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Wireless Capsule Endoscopy (Enteral

Camera)

Hereditary GI polyposis syndromes including familial polyposis

All diagnoses: Conventional endoscopic and diagnostic imaging evaluations (e.g. upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedure) are inconclusive

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

DELAWARE

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Novitas Solutions Inc.

No published LCD for capsule endoscopy. Claims will be manually reviewed.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

152.0-152.9, 209.00-209.03, 211.2, 211.3, 280.0, 280.9, 285.1, 555.0-555.9, 562.02, 562.03, 569.85, 569.86, 578.0-578.9, 579.0-579.9, 759.6, 792.1

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 9: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Carefirst BCBS Obscure gastrointestinal bleeding Unlisted UnlistedSuspected Crohn's disease

http://notesnet.carefirst.com/ecommerce/medicalpolicy.nsf/vwwebtablex/cd17ab70a3b3f608852578d10055d47b?OpenDocument

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Wireless Capsule Endoscopy (Enteral

Camera)Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

DISTRICT OF COLUMBIA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Novitas Solutions Inc.

No published LCD for capsule endoscopy. Claims will be manually reviewed.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

Page 10: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part B

Suspected Crohn's disease

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

BCBS FL Suspected Crohn's disease

Obscure GI bleed

OGIB: Prior inconclusive upper and lower GI endoscopic studies

Cigna Obscure GI bleed

Capsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumor

Celiac disease

Humana Obscure GI bleed Unlisted

Capsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromes

Suspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnostic

Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 759.6, 578.0, 578.1,

578.9, 579.0, 792.1, V84.09

http://www.aetna.com/cpb/medical/data/500_599/0588.html

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

152.0-152.9, 211.2, 235.2,

280.0, 280.8, 280.9, 281.9,

285.9, 555.0-555.9, 558.9,

578.1-578.9, 579.0

Hereditary GI polyposis syndromes, including familial

adenomatous polyposis and Peutz-Jeghers

syndromehttp://mcgs.bcbsfl.com/

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower

endoscopy) are inconclusive

MAC: First Coast Service

Options

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify

source of bleeding

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic

tests such as SBFT

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=29310&ContrId=197&ver=3&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Florida&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

Continuous blood loss and anemia secondary to

obscure bleeding of the small bowel

280.0, 280.9, 555.0, 555.2,

555.9, 562.02, 562.03, 569.85,

578.9

Wireless Capsule

Endoscopy

Blood Loss: Colonoscopy, endoscopy or radiographic exams failed to reveal a

source of bleeding, or interaoperative enteroscopy is being considered

Crohn's: No evidence provided by conventional diagnostic tests such as small

bowel follow-through (SBFT) and upper and lower endoscopy

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of

the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-

US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Wireless Capsule

Endoscopy

Crohn's: Without evidence on conventional diagnostic tests such as SBFT, and

upper and lower endoscopy

555.0, 555.2, 555.9, 562.02,

562.03, 569.85, 578.9

FLORIDA

Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

** Documented reason why patient is not a candidate for conventional endoscopy.

There must be specific co-morbidities and complicating medical conditions that lead

the performing provider of the conventional endoscopy to believe that the

risk/benefit ratio of a conventional endoscopy was not maintained. Medical record

must also support how capsule endoscopy would contribute to the patient’s care

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy

are negative for source of bleedingWireless Capsule

Endoscopy

Page 11: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedCrohn's diseaseSuspected small intestinal tumors

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS GA Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.bcbsga.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

GEORGIA

Capsule Endoscopy Payer Guidelines - CPT 91110

Suspected or refractory malabsorptive syndromes (eg, Celiac disease)

MAC: Cahaba Government Benefit

AdministratorsMedicine: Wireless Capsule Imaging ** It is expected that this test will be performed only once during any episode of

illness

152.0-152.9, 197.4, 211.2, 211.3, 230.7, 235.2, 259.2, 280.0, 280.9, 285.1, 555.0, 555.2, 555.9, 557.0-557.9, 558.1, 558.2, 558.41, 558.42, 558.9, 562.02-562.03, 569.84, 569.86, 578.1-578.9, 579.0, 579.1, 579.8, 579.9, 792.1, V10.09

OGIB: Documented GI blood loss and anemia secondary to bleeding. Site not previously identified by upper GI endoscopy, colonoscopy, push enteroscopy or radiological procedureCrohn's: Suspected but undiagnosed Crohn's or when necessary to determine whether there is small bowel involvement

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30045&ContrId=216&ver=20&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed|Key|SAD|FAQ&PolicyType=Final&s=14&CntrctrType=9&CptHcpcsCode=91110&kq=true&bc=IAAAA

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

http://www.aetna.com/cpb/medical/data/500_599/0588.html

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

Page 12: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingSuspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Wellmark BCBS Suspected Crohn's disease UnlistedCapsule Endoscopy Obscure GI bleed

OGIB: Prior inconclusive upper and lower GI endoscopic studies

http://www.wellmark.com/Provider/MedPoliciesAndAuthorizations/MedicalPolicies/policies/capsule_endoscopy.aspx

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

IOWA

Capsule Endoscopy Payer Guidelines - CPT 91110

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

MAC: Wisconsin Physicians Service Continued GI blood loss and anemia secondary to

bleeding

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Blood Loss: EGD and colonoscopy have been performed during same episode of illnessCrohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=147&ver=15&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Iowa&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on one or more conventional diagnostic tests such as SBFT, upper endoscopy and lower endoscopy

Hereditary GI polyposis syndromes, including familiar adenomatous polyposis and Petz-Jeghers syndrome

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the test

Page 13: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Regence BCBS Obscure GI bleed OGIB: Prior inconclusive upper and lower GI endoscopic studies UnlistedSuspected Crohn's disease

http://blue.regence.com/trgmedpol/radiology/rad38.html

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Wireless Capsule Endoscopy as a

Diagnostic Technique inDisorders of the

Esophagus, Small Bowel, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopy

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

http://www.aetna.com/cpb/medical/data/500_599/0588.html

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

IDAHO

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Page 14: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part B Occult GI bleeding

Suspected angiodysplasias

Capsule Endoscopy

Suspected or known Crohn's disease

Colitis

Suspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

BCBS IL Suspected Crohn's disease 211.2, 555.0-555.9, 759.6

Obscure GI bleeding

Cigna Obscure GI bleed

Suspected Crohn's disease

Suspected small bowel tumor

Celiac disease

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Humana Obscure GI bleed Unlisted

Capsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromes

Suspected small intestinal tumors

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

United Healthcare GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnostic

Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower

endoscopy) are inconclusive

Capsule Endoscopy

OGIB: Cause undetected by standard diagnostic methods and evidenced by iron-

deficiency anemia not attributable to other etiology

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI,

colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy

and colonoscopy have been performed during same episode of illness; documented

GI bleeding and anemia secondary to blood loss

Crohn's: Documented suspicion of diagnosis or procedure was necessary to

determine small bowel involvement

Blood Loss: EGD and colonoscopy have been performed during same episode of

illness

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Carrier: Wisconsin

Physicians Service

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 759.6, 578.0, 578.1,

578.9, 579.0, 792.1, V84.09

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy

are negative for source of bleeding

Crohn's: Negative for evidence of disease on conventional diagnostic tests, such

as endoscopy and SBFT

152.0-152.9, 211.2, 235.2,

280.0, 280.8, 280.9, 281.9,

285.9, 555.0-555.9, 558.9,

578.1-578.9, 579.0

http://medicalpolicy.hcsc.net/medicalpolicy/home?corpEntCd=IL1&path=/templatedata/medpolicies/POLICY/data/RADIOLOGY/RAD601.042_2011-09-15&ctype=POLICY&cat=Radiology#hlink

Wireless Capsule

Endoscopy (WCE) Hereditary GI polyposis syndromes, including familial

adenomatous polyposis and Peutz-Jegher's

syndrome

ILLINOIS

Endo Capsule Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

** Medical records must document the need for the test, contain reports of previous

diagnostic procedures prior to capsule endoscopy but during the same episode of

illness

Continued GI blood loss and anemia secondary to

bleeding

152.0-152.9, 235.2, 280.0,

280.9, 537.82, 537.83, 555.0,

555.1, 555.2, 555.9, 558.9,

562.02, 562.03, 569.82,

569.84, 569.85, 578.1, 578.9,

579.0, 579.1, 579.9, 787.91,

792.1, 793.4

http://www.cms.gov/medicare-coverage-database/details/lcd-

details.aspx?LCDId=30141&ContrId=48&ver=15&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed%7cKey%7cSAD%7cFAQ&PolicyType=Final&s=19&KeyWord=capsule&KeyWordLookUp=Title&KeyWordSearchType=

Exact&kq=true&bc=IAAAABAAAAAA&

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Wireless Capsule

Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of

the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-

US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify

source of bleeding

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic

tests such as SBFT

Page 15: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

Crohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulae

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

INDIANA

Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Carrier: National Government Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Page 16: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingSuspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS KS Suspected Crohn's diseaseObscure GI bleeding

OGIB: Prior inconclusive upper and lower GI endoscopic studies

http://www.bcbsks.com/CustomerService/Providers/MedicalPolicies/policies/policies/WirelessCapsuleEndoscopy_DT_Disorders_SmallBowel_Esophagus_Colon_2011-08-19.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

211.2, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 578.0, 578.1, 578.9, 759.6, 780.60, 783.21, 787.91, 789.00, 789.01, 789.02, 789.03, 789.04, 789.05, 789.06, 789.07, 789.09

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopyWireless Capsule

Endoscopy as a Diagnostic Technique in Disorders of the Small

Bowel, Esophagus, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polposis and Peutz-Jeghers syndrome

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostics tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

KANSAS

Capsule Endoscopy Payer Guidelines - CPT 91110

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=148&ver=15&ContrVer=1&CoverageSelection=Both&ArticleType=All&PolicyType=Final&s=Kansas&KeyWord=capsule&KeyWordLookUp=Title&KeyWordSearchType=And&bc=gAAAABAAAAAA&

MAC: Wisconsin Physicians Service Continued GI blood loss and anemia secondary to

bleeding

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Blood Loss: EGD and colonoscopy have been performed during same episode of illnessCrohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

Page 17: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B GI bleedingSmall bowel neoplasmCrohn's disease

Endoscopy by Capsule

Evaluation prior to surgery

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Bluegrass Family Health Obscure GI bleedCrohn's diseaseSuspected small bowel tumor

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Other conditions: Suspected to originate in the small intestinal mucosa. Prior negative or non-diagnostic evaluations of the stomach, duodenum/small intestine, and colon by flexible endoscopy, and complementary radiologic procedures and/or microbiologic studies must be documented

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

Crohn's: Following inconclusive SBFT and upper and lower endoscopy [EGD] and colonoscopy

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evalution (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

KENTUCKY

Capsule Endoscopy Payer Guidelines - CPT 91110

GI bleed: Site of bleeding not previously identified by any of the following: upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedures. Documented continuing GI blood loss or anemia secondary to bleeding or iron deficiency anemia

MAC: CGS Administrators, LLC

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=31838&ContrId=228&ver=11&ContrVer=2&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Kentucky&CptHcpcsCode=91110&Date=04%2f15%2f2012&bc=gAAAABAAAAAA&

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 197.4, 209.00, 209.01, 209.02, 209.03, 209.40, 209.41, 209.42, 209.43, 211.2, 211.3, 230.7, 235.2, 280.0, 457.1, 555.0, 555.1, 555.2, 555.9, 558.41, 558.42, 558.9, 560.0, 560.9, 562.02, 562.03, 564.1, 569.82, 569.84, 569.85, 569.86, 578.0, 578.1, 578.9, 579.8, 759.6, 787.91, 789.01, 789.02, 789.03, 789.04, 789.05, 789.06, 789.07, 789.09, 792.1, 793.4, V45.89

Surgery: Coverage limited to patients who are contemplated for surgical resection of the small bowel to control recurrent bleeding or protein loss is reasonable

Other conditions (malabsorption syndrome, chronic diarrhea, or protein-losing enteropathy) Small bowel neoplasm: Diagnosis not previously confirmed by other studies (e.g.,

upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedures). Patient must be symptomatic for neoplasm (e.g., GI bleeding) or have a documented polyposis syndrome associated with small bowel neoplasia or there is other history suggesting presence of small bowel neoplasia and other diagnostic testing to assess these symptoms (i.e., upper GI endoscopy and/or colonoscopy) must have been performedCrohn's: Condition not been previously confirmed or when a diagnosis of colitis of an indeterminate type affecting the colon is known, and a more specific diagnosis is sought by evaluating for small bowel involvement

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

OGIB: When there is iron deficiency anemia, a positive fecal occult blood test, or visible bleeding

152.0-152.9, 211.2, 235.2, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Video Capsule Endoscopy

http://www.healthcare-resolutions.com/DocMgt/ClientView/viewdocs/DocDisplay.aspx?T=20120406130354

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

Page 18: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: NHIC, Corp

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS MA Obscure GI bleed OGIB: Upper GI endoscopy and colonoscopy failed to reveal source of bleedingSmall bowel neoplasmCrohn's disease

https://www.bluecrossma.com/common/en_US/medical_policies/185_Wireless_Capsule_Endoscopy_as_a_Diagnostic_Technique_in_Disorders_of_the_Small_Bowel,_Esophagus,_and_Colon_prn.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

No published LCD for capsule endoscopy. Claims will be manually reviewed.

MASSACHUSETTS

Capsule Endoscopy Payer Guidelines - CPT 91110

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Wireless Capsule Endoscopy as a

Diagnostic Technique in Disorders of the Small

Bowel, Esophagus, and Colon

152.0-152.9, 197.4, 211.2, 230.7, 280.0, 555.0, 560.9, 562.02, 562.03, 569.85, 569.86, 578.1, 578.9, 787.91, 789.00-789.09, 792.1

Neoplasm: Upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging or radiological procedures have failed to identify a tumorCrohn's: Complete lower GI studies have failed to reveal the source of the patient's symptoms

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Page 19: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Carefirst BCBS Obscure gastrointestinal bleeding Unlisted UnlistedSuspected Crohn's disease

http://notesnet.carefirst.com/ecommerce/medicalpolicy.nsf/vwwebtablex/cd17ab70a3b3f608852578d10055d47b?OpenDocument

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Wireless Capsule Endoscopy (Enteral

Camera)

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

MARYLAND

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

MAC: Novitas Solutions Inc

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Page 20: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: NHIC, Corp

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Harvard Pilgrim Obscure GI bleed UnlistedSuspected or known Crohn's diseaseIron deficiency anemia

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

280.0, 280.1, 280.8, 280.9, 280.9, 555.0, 555.1, 555.2, 555.9, 555.9, 578.0, 578.1, 578.9

Reimbursement for Wireless Capsule

Endoscopy

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

No published LCD for capsule endoscopy. Claims will be manually reviewed.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

https://www.harvardpilgrim.org/portal/page?_pageid=253,280120&_dad=portal&_schema=PORTAL

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

MAINE

Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

Page 21: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedSuspected angiodysplasias of the GI tractAnemia secondary to bleeding

Capsule Endoscopy Crohn's diseaseColitis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS MI Suspected Crohn's disease UnlistedObscure GI bleed

Angiodysplasia of intestine with hemorrhage

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

Priority Health Occult GI bleedCapsule Endoscopy Crohn's disease

Known Crohn's: When necessary to determine small bowel involvement

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

Suspected small bowel neoplasm, regional enteritis, or malabsorption syndrome

MICHIGAN

Endo Capsule Capsule Endoscopy Payer Guidelines - CPT 91110

Carrier: Wisconsin Physicians Service

OGIB: Site of bleeding not previously identified by upper GI endoscopy, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy were performed during same episode of illness in anemic patientAngiodysplasias: EGD endoscopy and colonoscopy have been performed during same episode of illnessAnemia: Documented continuing GI blood loss, anemia secondary to bleeding, and EGD and colonoscopy were performed during same episode of illness

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://www.aetna.com/cpb/medical/data/500_599/0588.html

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=49&ver=15&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed|Key|SAD|FAQ&PolicyType=Final&s=27&CptHcpcsCode=91110&kq=true&bc=IAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

http://www.bcbsm.com/mprApp/MedicalPolicyDocument?fileId=2040202

Wireless Capsule Endoscopy as a

Diagnostic Technique in Disorders of the Small

Bowel, Esophagus, and Colon

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Colitis: colitis of an indeterminate type, affecting the colon, is known and a more specific diagnosis is sought by evaluating possible small bowel involvement

http://www.priorityhealth.com/provider/manual/auths/~/media/documents/medical-policies/91476.ashx

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

OGIB: Documented continuing GI blood loss and anemia secondary to bleeding. Siteof bleeding not identified by upper GI endoscopy, colonoscopy within the same episode of illness

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleedingWireless Capsule

Endoscopy

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Crohns: Suspected Crohn's disease or when diagnosis is known but it is necessary to determine whether there is involvement of the small bowel

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the test

152.0-152.9, 235.2, 280.0, 280.9, 285.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 792.1, 793.4

Surveillance of small bowel in patients with hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: No evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopyOGIB: Suspected to be of small bowel origin, as evidenced by prior inconclusive upper and lower GI endoscopic studies

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Suspected Crohn's: Upper GI endoscopy, colonoscopy and either push enteroscopy or small bowel radiologic study within the same period of illness which failed to reveal a focus of disease

Page 22: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingSuspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS MN Obscure GI bleed OGIB: Evaluation by upper and lower endoscopies has been inconclusive UnlistedSuspected Crohn's disease Crohn's: Conventional diagnostic tests have been inconclusive

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Continued GI blood loss and anemia secondary to bleeding

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Blood Loss: EGD and colonoscopy have been performed during same episode of illness

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://notes.bluecrossmn.com/web/medpolman.nsf/8178b1c14b1e9b6b8525624f0062fe9f/cb15528d4acadcca86256bc200499aa6/$FILE/Wireless%20Capsule%20Endoscopy.pdf

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Wireless Capsule Endoscopy Hereditary GI polyposis syndromes including familial

adenomatous polyposis and Peutz-Jeghers syndrome

MINNESOTA

Capsule Endoscopy Payer Guidelines - CPT 91110

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

Carrier: Wisconsin Physicians Service

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=50&ver=15&ContrVer=1&Date=&DocID=L30141&SearchType=Advanced&bc=KAAAAAgAAAAA&

Crohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Page 23: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to

Policy Coverage Pre-requisites Covered ICD-9 CodesMedicare Part B Occult GI bleeding

Suspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

MAC: Wisconsin Physicians Service

http://www.aetna.com/cpb/medical/data/500_599/0588.html

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=149&ver=15&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Missouri+-+Entire+State&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

Continued GI blood loss and anemia secondary to bleeding

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Crohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulae

MISSOURI

Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Blood Loss: EGD and colonoscopy have been performed during same episode of illnessCrohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

Page 24: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedCrohn's diseaseSuspected small intestinal tumors

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS MS Suspected Crohn's diseaseObscure GI bleeding

OGIB: Prior inconclusive upper and lower gastrointestinal endoscopic studies

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

209.40, 209.41, 209.42, 209.43, 211.2, 280.0, 280.8, 280.8, 280.9, 555.0, 555.1, 555.2, 555.9, 578.0, 578.1, 578.9, 759.6

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Suspected or refractory malabsorptive syndromes (eg, Celiac disease)

OGIB: Documented GI blood loss and anemia secondary to bleeding. Site not previously identified by upper GI endoscopy, colonoscopy, push enteroscopy or radiological procedureCrohn's: Suspected but undiagnosed Crohn's or when necessary to determine whether there is small bowel involvement** It is expected that this test will be performed only once during any episode of illness

http://www.bcbsms.com/index.php?q=provider-medical-policy-search.html&action=viewPolicy&path=policy%2Femed%2FWireless+Capsule+Endoscopy+as+a+Diagnositc+Technique+in+Disorders+of+the+Small+Bowel+Esophagus.html&keywords=capsule

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopyWireless Capsule

Endoscopy for Esophageal and Small Bowel Imaging and the

Patency Capsule

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

MISSISSIPPI

Capsule Endoscopy Payer Guidelines - CPT 91110

152.0-152.9, 197.4, 211.2, 211.3, 230.7, 235.2, 259.2, 280.0, 280.9, 285.1, 555.0, 555.2, 555.9, 557.0-557.9, 558.1, 558.2, 558.41, 558.42, 558.9, 562.02-562.03, 569.84, 569.86, 578.1-578.9, 579.0, 579.1, 579.8, 579.9, 792.1, V10.09

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30626&ContrId=10&ver=9&ContrVer=1&CntrctrSelected=10*1&Cntrctr=10&name=Cahaba+Government+Benefit+Administrators%24*%24sup*%24*%u00ae%24*%24%2fsup*%24*%2c+LLC+(00512%2c+Carrier)&s=31&bc=AggAAAIAAAAA&

Carrier: Cahaba Government Benefit

AdministratorsMedicine: Wireless

Capsule Imaging

Page 25: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS MT Suspected Crohn's disease UnlistedObscure GI bleeding

OGIB: Prior inconclusive upper and lower GI endoscopic studies

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

MONTANA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

https://www.bcbsmt.com/MedReview/Policies/WirelessCapsuleEndoscopySmallBowel/v101.aspx

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopyWireless Capsule

Endoscopy as a Diagnostic Technique in Disorders of the Small

Bowel, Esophagus, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Page 26: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedSmall bowel neoplasm or Regional enteritis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS NC Undiagnosed obscure gastrointestinal bleeding UnlistedCrohn's disease

http://www.bcbsnc.com/assets/services/public/pdfs/medicalpolicy/capsule_endoscopy_wireless.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

OGIB: Significant GI bleed demonstrated by acute drop in hemoglobin/hematocrit, unexplained recurrent or persistent iron deficiency anemia, persistently positive fecal occult blood test or visible bleeding with no bleeding source found at original endoscopy. Failure of upper and lower GI endoscopy to diagnose source of bleeding

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

NORTH CAROLINA

Capsule Endoscopy Payer Guidelines - CPT 91110

152.0-152.9, 211.2, 230.7, 235.2, 280.0, 280.9, 285.1, 537.82, 537.83, 537.84, 555.0, 555.2, 557.0-557.9, 558.1, 558.2, 562.02, 562.03, 569.82, 569.84, 569.85, 569.86, 578.1, 578.9, 579.8, 579.9, 759.6, 787.91, 792.1, 793.4

MAC: Palmetto Government Benefit

Administrators

OGIB: Anemia secondary to suspected occult blood loss, the origin of which is suspected to be in the small intestinal mucosa, based on documented negative or non-diagnostic prior evaluation of the stomach, duodenum (EGD) and colon (colonoscopy) by conventional instrumental endoscopy

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=31800&ContrId=233&ver=11&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed|Key|SAD|FAQ&PolicyType=Final&s=34&CntrctrType=9&CptHcpcsCode=91110&kq=true&bc=IAAAABAAAAAA&

Wireless Capsule Endoscopy

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Persistent abdominal pain greater than 4 weeks, persistent diarrhea, unintentional weight loss, negative stool cultures and negative upper and lower endoscopy studies

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Capsule Endoscopy, Wireless

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the test

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Page 27: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS ND Obscure GI bleeding UnlistedSuspected Crohn's diseaseKnown Crohn's disease

https://bb.thor.org/Bulletins/Blue_Cross_Blue_Shield_ND_Medical_Policy/Wireless_Capsule_Endoscopy.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

NORTH DAKOTA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome or Lynch syndrome

OGIB: Prior inconclusive upper and lower GI endoscopic studies must be documented

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

http://www.aetna.com/cpb/medical/data/500_599/0588.html

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Wireless Capsule Endoscopy

Monitoring and surveillance of small bowel mucosal healing for response to treatment

Page 28: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingSuspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS NE Obscure GI bleeding UnlistedSuspected Crohn's disease

https://www.nebraskablue.com/~/media/pdf/Provider/Policy%20Procedure%20Manuals/MedicalPolicies.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=151&ver=15&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed%7cKey%7cSAD%7cFAQ&PolicyType=Final&s=36&KeyWord=capsule+endoscopy&KeyWordLookUp=Doc&KeyWordSearchType=Exact&kq=true&bc=IAAAABAAAAAA&

Wireless Capsule Endoscopy and GI

Monitoring Systems

OGIB: Must have recurrent or persistent iron-deficiency anemia; positive fecal occult blood test; or visible bleeding with no bleeding source found at original endoscopy

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopy

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Crohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

http://www.aetna.com/cpb/medical/data/500_599/0588.html

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Wireless Capsule Endoscopy

NEBRASKA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Wisconsin Physicians Service Continued GI blood loss and anemia secondary to

bleeding

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Blood Loss: EGD and colonoscopy have been performed during same episode of illness

Page 29: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: NHIC, Corp

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Harvard Pilgrim Obscure GI bleed UnlistedSuspected or known Crohn's diseaseIron deficiency anemia

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

https://www.harvardpilgrim.org/portal/page?_pageid=253,280120&_dad=portal&_schema=PORTAL

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

NEW HAMPSHIRE

Capsule Endoscopy Payer Guidelines - CPT 91110

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

http://www.aetna.com/cpb/medical/data/500_599/0588.html

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Reimbursement for Wireless Capsule

Endoscopy

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

280.0, 280.1, 280.8, 280.9, 280.9, 555.0, 555.1, 555.2, 555.9, 555.9, 578.0, 578.1, 578.9

Page 30: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Horizon BCBS Obscure GI bleed OGIB: Prior inconclusive upper AND lower gastrointestinal endoscopic studies UnlistedSuspected Crohn's disease

https://services3.horizon-bcbsnj.com/hcm/MedPol2.nsf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

Oxford Health Plans GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac Disease: Prior serology or GI endoscopy are not diagnosticSmall Bowel Tumor: Imaging studies or GI endoscopy failed to confirm tumor

https://www.oxhp.com/secure/policy/wireless_capsule_endoscopy_212.html

April 2012

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss/Iron-deficiency anemia: Other diagnostic methods (upper endoscopy and colonoscopy) failed to identify source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 578.0, 578.1, 578.9, 579.0, 759.6, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopic examination fail to

reveal the location or extent of the pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

No published LCD for capsule endoscopy. Claims will be manually reviewed.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

NEW JERSEY

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Novitas Solutions Inc.

Wireless Capsule Endoscopy as a

Diagnostic Technique in Disorders of the Small

Bowel and Colon

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopy

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

Page 31: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingCeliac diseaseSuspected or known Crohn's diseaseColitis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS NM Suspected Crohn's disease 211.2, 555.0-555.9, 759.6Obscure GI bleed

http://medicalpolicy.hcsc.net/medicalpolicy/home?corpEntCd=NM1&path=/templatedata/medpolicies/POLICY/data/RADIOLOGY/RAD601.042_2011-09-15&ctype=POLICY&cat=Radiology#hlink

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Wireless Capsule Endoscopy (WCE)

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

OGIB: Cause has been undetected by standard diagnostic methods (i.e. colonoscopy and upper gastric endoscopy), AND that is evidenced by recurrent or persistent iron deficiency anemia, positive fecal occult blood test, or visible bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests, such as endoscopy and SBFT

NEW MEXICO

Capsule Endoscopy Payer Guidelines - CPT 91110

http://cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=26816&ContrId=158&ver=29&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&ArticleType=Ed%7cKey%7cSAD%7cFAQ&PolicyType=Final&s=39&KeyWord=capsule+endoscopy&KeyWordLookUp=Doc&KeyWordSearchType=Exact&kq=true&bc=IAAAABAAAAAA&

MAC: Trailblazer Health Enterprises, LLCWireless Capsule

Endoscopy

OGIB: Source of bleeding not previously identified by upper GI and colonoscopy and any of the following: push enteroscopy, nuclear imaging or radiological procedures; medical record must indicate if anemia is present

014.80-014.86, 152.0-152.3, 152.8, 152.9, 197.4, 211.2, 230.7, 251.5, 280.9, 447.6, 537.83-537.84, 555.0-555.2, 555.9, 557.1, 558.1, 562.02-562.03, 569.85-569.86, 578.1, 579.0, 792.1

Page 32: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: Palmetto GBA

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

OGIB: After appropriate evalution (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

NEVADA

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 33: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Emblem (HIP/GHI) Occult GI bleeding Unlisted

Iron deficiency anemia with confirmed blood loss

Suspected or known Crohn's disease Iron Deficiency Anemia: Documented anemia secondary to blood loss

Colitis

Small bowel neoplasm

Infammatory bowel disease

Colitis: Documented that test is necessary to evaluate small bowel involvement

Arteriovenous malformations of lymphangiectasia

Inflammatory Bowel: Presence of abdominal pain, occult or overt GI bleeding,

http://www.emblemhealth.com/pdf/med_guidelines/radio/MG_Wireless_Capsule_Endoscopy_b.pdf

Empire BCBS Obscure GI bleed

Crohn's disease

Diagnostic re-evaluation of Crohn's disease

Suspected small intestinal tumors

Lynch syndrome or polyposis syndromes

Refractory undiagnosed malabsorptive syndromes

Iron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.empireblue.com/medicalpolicies/policies/mp_pw_a050543.htm

Excellus BCBS Obscure GI bleed Unlisted

Suspected Crohn’s disease

https://www.excellusbcbs.com/wps/wcm/connect/9a1f84804e8eb72092f9bfe420b83c88/mp+wireless_endo+tac+11.pdf?MOD=AJPERES

Oxford Health Plans GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac Disease: Prior serology or GI endoscopy are not diagnostic

Small Bowel Tumor: Imaging studies or GI endoscopy failed to confirm tumorhttps://www.oxhp.com/secure/policy/wireless_capsule_endoscopy_212.html

March 2012

Capsule Endoscopy

(Camera Pill)

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 578.0, 578.1, 578.9,

579.0, 759.6, 792.1, V84.09

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Crohn's: Prior radiological study to exclude stricture, which did not demonstrate the

presence of Crohn's disease. Abdominal pain, occult or overt GI bleeding, diarrhea

and weight loss must all be present

Small Bowel Neoplasm: Diagnosis not previously confirmed by other studies.

Abdominal pain, occult or overt GI bleeding, diarrhea and weight loss must all be

present; or documented associated polyposis syndrome; or other history suggesting

the presence of small bowel neoplasia and have undergone prior diagnostic testing

to assess these symptoms

Evaluation of malabsorptions syndrome or protein-

losing enteropathy of obscure origin

Malabsorptions Syndrome: Diarrhea with greasy voluminous foul smelling stool,

and weight loss despite adequate food intake or anorexia, flatulence and abdominal

distention

Lymphangiectasia: For surgical resection of the small bowel to control recurrent

bleeding or protein loss is reasonable

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has

excluded a source of bleeding in the upper GI tract or colon

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Wireless Capsule

Endoscopy

Wireless Capsule

Endoscopy for the

Examination of the GI

Tract

Wireless Capsule

Endoscopy for

Esophageal and Small

Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no

suspected or confirmed GI obstruction, stricture, or fistulae

Lynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

GI blood loss/Iron-deficiency anemia: Other diagnostic methods (upper

endoscopy and colonoscopy) failed to identify source of bleeding

Crohn's: Imaging studies and/or upper or lower GI endoscopic examination fail to

reveal the location or extent of the pathology, and treatment decisions would be

affected by the results of the test

OGIB: Documented presence of GI bleeding and negative upper and lower

endoscopies performed during current episode of illness

NEW YORK

Endo Capsule Capsule Endoscopy Payer Guidelines - CPT 91110

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Peutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopy

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

MAC: National

Government Services

**Procedure should be performed under the supervision of a gastroenterologist or

general surgeon with expertise in this technology

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with

urinalysis and examination of abdomen and pelvis has excluded a source of anemia

from the GU region, upper GI tract and colon

OGIB: Conventional diagnostic work-up (colonoscopy, upper endoscopy, and in

some situations, a small bowel series) that has not revealed source of bleeding

Crohn's: Conventional diagnostic work-up failed to reveal lesions consistent with

disease and there remains strong clinical suspicion of CD (fever, weight loss,

anemia, elevated WBC, and/or elevated sedimentation rate)

Hereditary GI polyposis syndromes such as familial

adenomatosis polyposis (FAP) or Peutz-Jeghers

syndrome

152.0-152.9, 153.0-153.9,

154.0-154.1, 154.8, 209.00-

209.03, 211.2, 235.2, 280.0-

280.9, 555.0-555.9, 578.0-

578.9, 579.0-579.9, V12.72,

V71.1, V71.89

Crohn's re-evaluation: Symptomatic after appropriate treatment has occurred and

there is no suspected or confirmed GI obstruction, stricture or fistulae

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g.

suspected celiac disease with prior negative biospy)

Page 34: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B GI bleedingSmall bowel neoplasmCrohn's disease

Endoscopy by Capsule

Evaluation prior to surgery

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Medical Mutual of Ohio Suspected occult blood loss UnlistedIron deficiency anemiaSmall bowel neoplasm or regional enteritis (Crohn's)Refractory undiagnosed malabsorptive syndromes

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease)All diagnoses: At least one of the following clinical conditions present: Malignant neoplasm of small intestine, including duodenum; Secondary malignant neoplasm of small intestine, including duodenum; Malignant carcinoid tumor of small intestine, unspecific portion; Malignant carcinoid tumor of the duodenum; Malignant carcinoid tumor of the jejunum; Malignant carcinoid tumor of the ileum; Benign carcinoid tumor of the small intestine, unspecified portion; Benign carcinoid tumor of the duodenum; Benign carcinoid tumor of the jejunum; Benign carcinoid tumor of the ileum; Benign neoplasm of duodenum, jejunum, and ileum; Benign neoplasm of colon; Carcinoma in situ of other and unspecified parts of intestine; Neoplasm of uncertain behavior of stomach, intestines, and rectum; Iron deficiency anemias secondary to blood loss (chronic); Iron deficiency anemia, unspecified; Acute posthemorrhagic anemia; Other lymphedema; Regional enteritis of large intestine; Other specified disorders of stomach and duodenum; Regional enteritis of small intestine; Regional enteritis of small intestine with largeintestine; Vascular insufficiency of intestine; Gastroenteritis and colitis due to radiation; Toxic gastroenteritis and colitis; Other and unspecified noninfectious gastroenteritis and colitis; Intussusception; Unspecified intestinal obstruction; Diverticula of small intestine; Irritable bowel syndrome; Other specified disorders of intestine; GI hemorrhage; Other specified intestinal malabsorption; Unspecified intestinal malabsorption; Other hamartoses, not elsewhere classified; Diarrhea; Abdominal pain; Nonspecific abnormal findings in stool contents; Nonspecific abnormal findings in radiological and other examinations of GI tract

Other conditions (malabsorption syndrome, chronic diarrhea, or protein-losing enteropathy)

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=29310&ContrId=197&ver=3&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Florida&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

OHIO

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: CGS Administrators, LLC

GI bleed: Site of bleeding not previously identified by any of the following: upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedures. Documented continuing GI blood loss or anemia secondary to bleeding or iron deficiency anemia

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 197.4, 209.00, 209.01, 209.02, 209.03, 209.40, 209.41, 209.42, 209.43, 211.2, 211.3, 230.7, 235.2, 280.0, 457.1, 555.0, 555.1, 555.2, 555.9, 558.41, 558.42, 558.9, 560.0, 560.9, 562.02, 562.03, 564.1, 569.82, 569.84, 569.85, 569.86, 578.0, 578.1, 578.9, 579.8, 759.6, 787.91, 789.01, 789.02, 789.03, 789.04, 789.05, 789.06, 789.07, 789.09, 792.1, 793.4, V45.89

Small bowel neoplasm: Diagnosis not previously confirmed by other studies (e.g., upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedures). Patient must be symptomatic for neoplasm (e.g., GI bleeding) or have a documented polyposis syndrome associated with small bowel neoplasia or there is other history suggesting presence of small bowel neoplasia and other diagnostic testing to assess these symptoms (i.e., upper GI endoscopy and/or colonoscopy) must have been performed.Crohn's: Condition not been previously confirmed or when a diagnosis of colitis of an indeterminate type affecting the colon is known, and a more specific diagnosis is sought by evaluating for small bowel involvementOther conditions: Suspected to originate in the small intestinal mucosa. Prior negative or non-diagnostic evaluations of the stomach, duodenum/small intestine, and colon by flexible endoscopy, and complementary radiologic procedures and/or microbiologic studies must be documented.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or

extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Surgery: Coverage limited to patients who are contemplated for surgical resection of the small bowel to control recurrent bleeding or protein loss is reasonable

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

https://provider.medmutual.com/TOOLS_and_RESOURCES/Care_Management/MedPolicies/PDF/200214.pdf#xml=http://dmzsearch.antaressolutions.com/texis/search/pdfhi.txt?query=capsule+endoscopy&pr=MedPolicies&prox=page&rorder=500&rprox=500&rdfreq=500&rwfreq=500&rlead=500&rdepth=0&sufs=0&order=r&cq=&id=4ede59f67

Wireless Capsule Endoscopy - Esophagus

through Ileum

Blood loss: GI blood loss or anemia where small bowel is suspected bleeding source and investigation of the stomach, duodenum and colon were unremarkable or non-diagnostic by EGD or colonoscopyIron deficiency anemia: Unexplained by other factors (e.g., menstrual history, blood donation history)Small bowel neoplasm/Crohn's: Primary evaluation demonstrates signs and symptoms

Page 35: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingCeliac diseaseSuspected or known Crohn's diseaseColitis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS OK Suspected Crohn's disease 211.2, 555.0-555.9, 759.6Obscure GI bleed

http://medicalpolicy.hcsc.net/medicalpolicy/home?ctype=POLICY&cat=Radiology&path=/templatedata/medpolicies/POLICY/data/RADIOLOGY/RAD601.042_2011-09-15#hlink

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

OKLAHOMA

Capsule Endoscopy Payer Guidelines - CPT 91110

014.80-014.86, 152.0-152.3, 152.8, 152.9, 197.4, 211.2, 230.7, 251.5, 280.9, 447.6, 537.83-537.84, 555.0-555.2, 555.9, 557.1, 558.1, 562.02-562.03, 569.85-569.86, 578.1, 579.0, 792.1

MAC: Trailblazer Health Enterprises, LLCWireless Capsule

Endoscopy

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=26816&ContrId=159&ver=29&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Oklahoma&CptHcpcsCode=91110&Date=04%2f15%2f2012&bc=gAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

OGIB: Source of bleeding not previously identified by upper GI and colonoscopy and any of the following: push enteroscopy, nuclear imaging or radiological procedures; medical record must indicate if anemia is present

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Wireless Capsule Endoscopy (WCE)

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Without evidence of disease on conventional diagnostic tests, such as endoscopy and SBFT

OGIB: Cause has been undetected by standard diagnostic methods (i.e. colonoscopy and upper gastric endoscopy), AND that is evidenced by recurrent or persistent iron deficiency anemia, positive fecal occult blood test, or visible bleeding

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Page 36: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Regence BCBS Obscure GI bleed OGIB: Prior inconclusive upper and lower GI endoscopic studies UnlistedSuspected Crohn's disease

http://blue.regence.com/trgmedpol/radiology/rad38.html

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.aetna.com/cpb/medical/data/500_599/0588.html

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

OREGON

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Wireless Capsule Endoscopy as a

Diagnostic Technique inDisorders of the

Esophagus, Small Bowel, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopy

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Page 37: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Cigna Obscure GI bleed

Capsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumor

Celiac disease

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Highmark BCBS Angiodysplasias of the GI tract

Suspected Crohn's disease

Occult GI bleed

Peutz-Jeghers syndrome

Celiac Disease: Negative biopsy

Suspected small bowel turmorshttps://secure.highmark.com/ldap/medicalpolicy/wpa-highmark/G-41-015.html

Occult/Obscure GI bleeding

Small bowel neoplasm

Crohn's disease

Evaluation prior to surgery

http://medpolicy.ibx.com/policies/mpi.nsf/88c0c50066c9d059852574d300564913/126c59e615c110a085257837004df09c!OpenDocument

United Healthcare GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnostic

Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

Suspected or refractory malabsorptive syndromes

(Celiac disease)

All diagnoses: Inconclusive conventional endoscopy and diagnostic imaging

evaluations (upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging,

or radiological procedure)

Independence Blue

Cross Wireless Capsule

Endoscopy (WCE) using

the Given® Diagnostic

Imaging and PillCam™

Capsule Systems

Small bowel neoplasm: Diagnosis previously unconfirmed by upper GI endoscopy,

push enteroscopy, nuclear imaging or radiological procedures. Must be symptomatic

for neoplasm (GI bleeding), documented hereditary polyposis syndrome associated

with small bowel neoplasia, or have other history suggesting presence of small

bowel neoplasia. Other diagnostic testing to assess these symptoms (upper GI

endoscopy and/or colonoscopy) have have been performed

Other conditions (Suspected or refractory

malabsorption syndromes (eg, Celiac disease),

chronic diarrhea, or protein-losing enteropathy)

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower

endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2,

280.0, 280.8, 280.9, 281.9,

285.9, 555.0-555.9, 558.9,

578.1-578.9, 579.0

Wireless Capsule

Endoscopy

152.0-152.9, 209.00-209.03,

211.2, 211.3, 280.0, 280.9,

285.1, 555.0-555.9, 562.02,

562.03, 569.85, 569.86, 578.0-

578.9, 579.0-579.9, 759.6,

792.1

Hereditary GI polyposis syndromes including familial

polyposis

Crohn's: Suspected but unconfirmed, without evidence of disease on conventional

diagnostic test, such as SBFT and upper and lower endoscopy

Surgery: Limited to individuals who are being considered for surgical resection of

the small bowel to control recurrent bleeding or protein loss is appropriate

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-

US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 197.4, 209.00,

209.01, 209.02, 209.03,

209.40, 209.41, 209.42,

209.43, 211.2, 211.3, 230.7,

235.2, 280.0, 280.9, 538,

555.0, 555.1, 555.2, 555.9,

558.9, 560.89, 560.9, 562.02,

562.03, 564.1, 569.82, 569.84,

569.85, 569.86, 569.9, 571.2,

571.5, 571.6, 572.3, 578.0,

578.1, 578.9, 579.8, 579.9,

759.6, 787.91, 789.00, 789.01,

789.02, 789.03, 789.04,

789.05, 789.06, 789.07,

789.09, 792.1, 793.4

OGIB: Recurrent or persistent iron-defiency anemia suspected of being of small

bowel origin, as evidence by prior inconclusive upper and lower endoscopic studies

OGIB: Iron deficiency anemia or acute posthemorrhagic anemia, the site of which

has not been previously identified; positive fecal occult blood test or visible bleeding

with no bleeding source found at original endoscopy

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 759.6, 578.0, 578.1,

578.9, 579.0, 792.1, V84.09

Other conditions: Suspected to originate in the small intestinal mucosa. Prior

negative or non-diagnostic evaluations of the stomach, duodenum/small intestine,

and colon by flexible endoscopy and complementary radiologic procedures and/or

microbiologic studies must be documented

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy

are negative for source of bleedingWireless Capsule

Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of

the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

PENNSYLVANIA

Endo Capsule Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.MAC: Novitas Solutions

Inc

Page 38: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Suspected Crohn's disease

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

Triple S Salud

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=29409&ContrId=198&ver=2&ContrVer=1&DocID=L29409&bc=gAAAAAgAAAAA&

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

No published medical policy for capsule endscopy. Claims will be manually reviewed.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

PUERTO RICO

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: First Coast Service Options

Wireless Capsule Endoscopy

Continuous blood loss and anemia secondary to obscure bleeding of the small bowel

Blood Loss: Colonoscopy, endoscopy or radiographic exams failed to reveal a source of bleeding, or interaoperative enteroscopy is being consideredCrohn's: No evidence provided by conventional diagnostic tests such as small bowel follow-through (SBFT) and upper and lower endoscopy** Documented reason why patient is not a candidate for conventional endoscopy. There must be specific co-morbidities and complicating medical conditions that lead the performing provider of the conventional endoscopy to believe that the risk/benefit ratio of a conventional endoscopy was not maintained. Medical record must also support how capsule endoscopy would contribute to the patient’s care

280.0, 280.9, 555.0, 555.2, 555.9, 562.02, 562.03, 569.85, 578.9

Page 39: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: NHIC, Corp

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS RI Obscure GI bleeding UnlistedSuspected Crohn's disease

https://www.bcbsri.com/BCBSRIWeb/pdf/medical_policies/WirelessCapsuleEndoscopy.pdf

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

Neighborhood Health Occult GI bleeding and anemia UnlistedCapsule Endoscopy Suspected Angiodysplasia of the GI tract

Suspected Crohn's diseaseKnown Crohn's diseaseColitisSmall bowel neoplasmRegional enteritisMalabsorption syndromeCeliac disease

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: Upper and lower GI endoscopies (EGD and colonoscopy) that have failed to identify a bleeding sourceWireless Capsule

Endoscopy-PREAUTH Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.nhpri.org/matriarch/documents/CMP-011.02%20Capsule%20Endoscopy.7-11.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

Crohn's: Without evidence of disease on conventional diagnostic tests, including upper and lower endoscopy (EGD, colonoscopy), and small-bowel evaluation such as upper GI with SBFT or MR enterography or CT enterography

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

OGIB: Upper endoscopy and colonoscopy, or push endoscopy or other radiologic procedures, and EGD endoscopy and colonoscopy have been performed during the same episode of illnessAngiodysplasia: EGD endoscopy and colonoscopy have been performed during the same episode of illness

RHODE ISLAND

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 40: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedMAC: Palmetto GBA Small bowel neoplasm or Regional enteritis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS SC Suspected Crohn's disease UnlistedObscure GI bleed

OGIB: Prior inconclusive upper and lower gastrointestinal endoscopic studies

http://www.cam-policies.com/internet/cmpd/cmp/mdclplcy.nsf/DispContent/7CA11E51C222C4018525717100479185?opendocument

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the test

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Wireless Capsule Endoscopy

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopyWireless Capsule

Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel, Esophagus and

Colon

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=31800&ContrId=234&ver=11&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=South+Carolina&CptHcpcsCode=91110&Date=04%2f15%2f2012&bc=gAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

SOUTH CAROLINA

Capsule Endoscopy Payer Guidelines - CPT 91110

OGIB: Anemia secondary to suspected occult blood loss, the origin of which is suspected to be in the small intestinal mucosa, based on documented negative or non-diagnostic prior evaluation of the stomach, duodenum (EGD) and colon (colonoscopy) by conventional instrumental endoscopy

152.0-152.9, 211.2, 230.7, 235.2, 280.0, 280.9, 285.1, 537.82, 537.83, 537.84, 555.0, 555.2, 557.0-557.9, 558.1, 558.2, 562.02, 562.03, 569.82, 569.84, 569.85, 569.86, 578.1, 578.9, 579.8, 579.9, 759.6, 787.91, 792.1, 793.4

Wireless Capsule Endoscopy

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Page 41: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Wellmark BCBS Suspected Crohn's disease UnlistedCapsule Endoscopy Obscure GI bleed

OGIB: Prior inconclusive upper and lower GI endoscopic studies

ttp://www.wellmark.com/Provider/MedPoliciesAndAuthorizations/MedicalPolicies/policies/capsule_endoscopy.aspx

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Hereditary GI polyposis syndromes, including familiar adenomatous polyposis and Petz-Jeghers syndrome

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on one or more conventional diagnostic tests such as SBFT, upper endoscopy and lower endoscopy

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

SOUTH DAKOTA

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Page 42: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedCrohn's diseaseSuspected small intestinal tumors

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS TN Obscure GI bleed UnlistedSuspected Crohn's disease

http://www.bcbst.com/mpmanual/!SSL!/WebHelp/Ingestible_Video_Capsule_Imaging_of_the_Gastrointestinal_Tract.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Ingestible Video Capsule Imaging of the

Gastrointestinal Tract

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

OGIB: Positive fecal occult blood tests, visible bleeding, or recurrent or persistent iron-deficient anemia despite treatment AND inconclusive results from two or more standard accepted diagnostic tests Crohn's: Inconclusive results from two or more standard accepted diagnostic tests

TENNESSEE

Capsule Endoscopy Payer Guidelines - CPT 91110

152.0-152.9, 197.4, 211.2, 211.3, 230.7, 235.2, 259.2, 280.0, 280.9, 285.1, 555.0, 555.2, 555.9, 557.0-557.9, 558.1, 558.2, 558.41, 558.42, 558.9, 562.02-562.03, 569.84, 569.86, 578.1-578.9, 579.0, 579.1, 579.8, 579.9, 792.1, V10.09

MAC: Cahaba Government Benefit

Administrators Suspected or refractory malabsorptive syndromes (eg, Celiac disease)

OGIB: Documented GI blood loss and anemia secondary to bleeding. Site not previously identified by upper GI endoscopy, colonoscopy, push enteroscopy or radiological procedureCrohn's: Suspected but undiagnosed Crohn's or when necessary to determine whether there is small bowel involvement** It is expected that this test will be performed only once during any episode of illness

Medicine:Wireless Capsule Endoscopy

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30045&ContrId=218&ver=20&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Tennessee&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

Page 43: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name

Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes

(listed in policy)

Medicare Part B Occult GI bleeding

Celiac disease

Suspected or known Crohn's disease

Colitis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsy

Capsule Endoscopy Celiac disease

Suspected Crohn's disease

Suspected small intestinal bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

BCBS TX Crohn's disease 211.2, 555.0-555.9, 759.6

Obscure GI bleeding

Cigna Obscure GI bleed

Capsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumor

Celiac disease

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Humana Obscure GI bleed Unlisted

Capsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromes

Suspected small intestinal tumors

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

United Healthcare GI blood loss and/or iron-deficiency anemia

Suspected or known Crohn's disease

Celiac disease

Suspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnostic

Small bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

March 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule

to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more

intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and

comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report

and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses,

claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

152.0, 152.1, 152.2, 152.3,

152.8, 152.9, 209.00, 209.01,

209.02, 209.03, 211.2, 235.2,

280.0, 280.9, 555.0, 555.1,

555.2, 555.9, 558.1, 558.2,

558.3, 558.9, 562.02, 562.03,

569.85, 759.6, 578.0, 578.1,

578.9, 579.0, 792.1, V84.09

TEXAS

Capsule Endoscopy Payer Guidelines - CPT 91110

Wireless Capsule

Endoscopy (WCE)

209.00-209.03, 209.40-

209.43, 211.2, 280.0, 280.9,

285.1, 288.8, 555.0-555.9,

558.1-558.9, 578.0-578.9,

579.0, 759.6, 780.60, 780.61,

783.21, 787.91, 789.00-

789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever,

elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without

evidence of disease on conventional diagnostic tests, including SBFT, abdominal

CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a

bleeding source

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic

tests such as SBFT

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy

are negative for source of bleeding

MAC: Trailblazer Health

Enterprises, LLC

OGIB: Source of bleeding not previously identified by upper GI and colonoscopy

and any of the following: push enteroscopy, nuclear imaging or radiological

procedures; medical record must indicate if anemia is present

http://medicalpolicy.hcsc.net/medicalpolicy/home?corpEntCd=TX1&path=/templatedata/medpolicies/POLICY/data/RADIOLOGY/RAD601.042_2011-09-15&ctype=POLICY&cat=Radiology#hlink

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower

endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2,

280.0, 280.8, 280.9, 281.9,

285.9, 555.0-555.9, 558.9,

578.1-578.9, 579.0

014.80-014.86, 152.0-152.3,

152.8, 152.9, 197.4, 211.2,

230.7, 251.5, 280.9, 447.6,

537.83-537.84, 555.0-555.2,

555.9, 557.1, 558.1, 562.02-

562.03, 569.85-569.86, 578.1,

579.0, 792.1

Wireless Capsule

Endoscopy

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cms.gov/medicare-coverage-database/details/lcd-

details.aspx?LCDId=26816&ContrId=160&ver=29&ContrVer=1&SearchType=Advanced&CoverageSelection=Local&PolicyType=Final&s=51&CntrctrType=9&CptHcpcsCode=91110&kq=true&bc=IAAAABAAAAAA&

Hereditary GI polyposis syndromes, including familial

adenomatous polyposis and Peutz-Jeghers

syndrome

Crohn's: Negative for evidence of disease on conventional diagnostic tests, such

as endoscopy and SBFT

OGIB: Cause undetected by standard diagnostic methods and evidenced by iron-

deficiency anemia not attributable to other etiology

Wireless Capsule

Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of

the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-

Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-

US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify

source of bleeding

Page 44: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Regence BCBS Obscure GI bleed OGIB: Prior inconclusive upper and lower GI endoscopic studies UnlistedSuspected Crohn's disease

http://blue.regence.com/trgmedpol/radiology/rad38.html

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Wireless Capsule Endoscopy as a

Diagnostic Technique inDisorders of the

Esophagus, Small Bowel, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopy

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

UTAH

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 45: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedSmall bowel neoplasm or regional enteritis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=31800&ContrId=229&ver=11&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Virginia&KeyWord=capsule+endoscopy&KeyWordLookUp=Title&KeyWordSearchType=And&bc=gAAAABAAAAAA

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

VIRGINIA

Capsule Endoscopy Payer Guidelines - CPT 91110

OGIB: Anemia secondary to suspected occult blood loss, the origin of which is suspected to be in the small intestinal mucosa, based on documented negative or non-diagnostic prior evaluation of the stomach, duodenum (EGD) and colon (colonoscopy) by conventional instrumental endoscopy

152.0-152.9, 211.2, 230.7, 235.2, 280.0, 280.9, 285.1, 537.82, 537.83, 537.84, 555.0, 555.2, 557.0-557.9, 558.1, 558.2, 562.02, 562.03, 569.82, 569.84, 569.85, 569.86, 578.1, 578.9, 579.8, 579.9, 759.6, 787.91, 792.1, 793.4

MAC: Palmetto Government Benefit

AdministratorsWireless Capsule

Endoscopy

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

Page 46: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims
Page 47: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: NHIC, Corp

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS VT Suspected Crohn's disease UnlistedObscure GI bleeding

OGIB: Prior inconclusive upper and lower GI endoscopic studies

http://www.bcbsvt.com/export/sites/BCBSVT/provider/medicalpolicies/PDFs/Capsule_Endoscopy.pdf

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Crohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the test

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

Lynch syndrome or inherited polyposis syndromes such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleeding

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopyWireless Capsule

Endoscopy as a Diagnostic Technique in Disorders of the Small Bowel and Esophagus

VERMONT

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 48: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedingSuspected angiodysplasias

Capsule EndoscopySuspected or known Crohn's diseaseColitisSuspected small bowel neoplasm

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Anthem BCBS Obscure GI bleedCrohn's diseaseDiagnostic re-evaluation of Crohn's diseaseSuspected small intestinal tumorsLynch syndrome or polyposis syndromesRefractory undiagnosed malabsorptive syndromesIron deficiency anemia Lynch or Polyposis Syndromes: Patient must be age 35 or greater

http://www.anthem.com/medicalpolicies/policies/mp_pw_a050543.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

WISCONSIN

Capsule Endoscopy Payer Guidelines - CPT 91110

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=30141&ContrId=47&ver=15&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Wisconsin&CptHcpcsCode=91110&bc=gAAAABAAAAAA&

OGIB: Anemic patient when site of bleeding is not previously identified by upper GI, colonoscopy, push endoscopy or other radiologic procedure, and EGD endoscopy and colonoscopy have been performed during same episode of illness; documented GI bleeding and anemia secondary to blood loss

Angiodysplasias: EGD and colonoscopy performed during same episode of illness

Blood Loss: EGD and colonoscopy have been performed during same episode of illnessCrohn's: Documented suspicion of diagnosis or procedure was necessary to determine small bowel involvement

Carrier: Wisconsin Physicians Service Continued GI blood loss and anemia secondary to

bleeding

152.0-152.9, 235.2, 280.0, 280.9, 537.82, 537.83, 555.0, 555.1, 555.2, 555.9, 558.9, 562.02, 562.03, 569.82, 569.84, 569.85, 578.1, 578.9, 579.0, 579.1, 579.9, 787.91, 792.1, 793.4

** Medical records must document the need for the test, contain reports of previous diagnostic procedures prior to capsule endoscopy but during the same episode of illness

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Malabsorptive Syndromes: Prior history of negative small bowel biopsy (e.g. suspected celiac disease with prior negative biopsy)Iron Deficiency Anemia: Upper and lower endoscopy, GU assessment with urinalysis and examination of abdomen and pelvis has excluded a source of anemia from the GU region, upper GI tract and colon

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

OGIB: After appropriate evaluation (at minimum upper and lower endoscopy) has excluded a source of bleeding in the upper GI tract or colon

152.0-152.9, 153.0-153.9, 154.0-154.1, 154.8, 209.00-209.03, 211.2, 235.2, 280.0-280.9, 555.0-555.9, 578.0-578.9, 579.0-579.9, V12.72, V71.1, V71.89

Wireless Capsule Endoscopy for

Esophageal and Small Bowel Imaging and the

Patency Capsule

Crohn's: SBFT and upper and lower endoscopy are non-diagnostic AND there is no suspected or confirmed GI obstruction, stricture, or fistulaeCrohn's re-evaluation: Symptomatic after appropriate treatment has occurred and there is no suspected or confirmed GI obstruction, stricture or fistulae

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

Page 49: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Obscure GI bleedSmall bowel neoplasm or regional enteritis

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Highmark BCBS Angiodysplasias of the GI tract

Suspected Crohn's diseaseOccult GI bleedPeutz-Jeghers syndrome

Celiac Disease: Negative biopsy

Suspected small bowel turmors

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Hereditary GI polyposis syndromes including familial polyposis

Suspected or refractory malabsorptive syndromes (Celiac disease)

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

All diagnoses: Inconclusive conventional endoscopy and diagnostic imaging evaluations (upper GI endoscopy, colonoscopy, push enteroscopy, nuclear imaging, or radiological procedure)OGIB: Iron deficiency anemia or acute posthemorrhagic anemia, the site of which has not been previously identified; positive fecal occult blood test or visible bleeding with no bleeding source found at original endoscopy

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

https://www.highmarkbcbswv.com/west-virginia-commercial-medical-policy/G-41-013.html

Wireless Capsule Endoscopy

152.0-152.9, 209.00-209.03, 211.2, 211.3, 280.0, 280.9, 285.1, 555.0-555.9, 562.02, 562.03, 569.85, 569.86, 578.0-578.9, 579.0-579.9, 759.6, 792.1

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

http://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=31800&ContrId=235&ver=11&ContrVer=1&CntrctrSelected=235*1&Cntrctr=235&name=Palmetto+GBA+(11402%2c+MAC+-+Part+B)&LCntrctr=235*1&bc=AgACAAIAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

WEST VIRGINIA

Capsule Endoscopy Payer Guidelines - CPT 91110

152.0-152.9, 211.2, 230.7, 235.2, 280.0, 280.9, 285.1, 537.82, 537.83, 537.84, 555.0, 555.2, 557.0-557.9, 558.1, 558.2, 562.02, 562.03, 569.82, 569.84, 569.85, 569.86, 578.1, 578.9, 579.8, 579.9, 759.6, 787.91, 792.1, 793.4

MAC: Palmetto Government Benefit

AdministratorsWireless Capsule

Endoscopy

OGIB: Anemia secondary to suspected occult blood loss, the origin of which is suspected to be in the small intestinal mucosa, based on documented negative or non-diagnostic prior evaluation of the stomach, duodenum (EGD) and colon (colonoscopy) by conventional instrumental endoscopy

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel

Page 50: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS WY Suspected Crohn's diseaseObscure GI bleeding

OGIB: Prior inconclusive upper and lower GI endoscopic studies

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

211.2, 555.0-555.9, 578.0-578.9, 759.6

https://bb.noridian.com/Bulletins/Blue_Cross_Blue_Shield_WY_Medical_Policy/Wireless_Capsule_Endoscopy.htm

http://www.aetna.com/cpb/medical/data/500_599/0588.html

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT and upper and lower endoscopyWireless Capsule

Endoscopy as a Diagnostic Technique in Disorders of the Small

Bowel, Esophagus, and Colon

Hereditary GI polyposis syndromes, including familial adenomatous polyposis and Peutz-Jeghers syndrome

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

WYOMING

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Page 51: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part BMAC: Palmetto GBA

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

HMSACigna Obscure GI bleed

Capsule Endoscopy Suspected Crohn's diseaseSuspected small bowel tumorCeliac disease

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

No published medical policy for capsule endscopy. Claims will be manually reviewed.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

HAWAII

Capsule Endoscopy Payer Guidelines - CPT 91110

No published LCD for capsule endoscopy. Claims will be manually reviewed.

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Page 52: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B Occult GI bleedSuspected Angiodysplasias of the GI tractKnown Crohn's disease

Capsule Endoscopy

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

BCBS LA Suspected Crohn's diseaseObscure GI bleed

OGIB: Prior inconclusive upper and lower GI endoscopic studies

http://www.bcbsla.com/MedicalPolicies/0013720110914WirelessCapsuleEndoscopyasaDiagnosticTechniqueinDisordersoftheEsophagus,SmallBowel_11267.pdf

Humana Obscure GI bleed UnlistedCapsule Endoscopy Suspected Crohn's or Celiac disease

Polyposis syndromesSuspected small intestinal tumors

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

LOUISIANA

Capsule Endoscopy Payer Guidelines - CPT 91110

Carrier: Pinnacle Business Solutions, Inc.

http://www.aetna.com/cpb/medical/data/500_599/0588.html

OGIB: Not previously identified by upper GI endoscopy, colonoscopy, push endoscopy or other radiologic procedure

280.9, 555.0-555.9, 578.1, 578.9, 792.1

https://www.cms.gov/medicare-coverage-database/details/lcd-details.aspx?LCDId=13489&ContrId=3&ver=13&ContrVer=1&CoverageSelection=Local&ArticleType=All&PolicyType=Final&s=Louisiana&CptHcpcsCode=91110&Date=04%2f15%2f2012&bc=gAAAABAAAAAA&

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopyPeutz-Jeghers syndrome and other polyposis

syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and lower GI endoscopies within the last 12 months that have failed to identify a bleeding source

Hereditary gastrointestinal polyposis syndromes, including familiar adenomatous polyposis and Peutz-Jeghers

Crohn's: Without evidence of disease on conventional diagnostic tests such as SBFT, and upper and lower endoscopy

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Wireless Capsule Endoscopy as a

Diagnostic Technique inDisorders of the

Esophagus, Small Bowel and Colon

OGIB: Push enteroscopy, small bowel series and/or enteroclysis failed to identify source of bleedingCrohn's or Celiac disease: No evidence of disease found via standard diagnostic tests such as SBFT

211.2, 555.0-556.9, 578.0-578.9, 759.6

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location

or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Page 53: ALASKA Capsule Endoscopy Payer Guidelines - … Capsule Endoscopy Payer Guidelines - CPT 91110 MAC: Noridian Administrative Services No published LCD for capsule endoscopy. Claims

Payer / Policy Name Link to Policy

Policy Coverage Pre-requisites Covered ICD-9 Codes (listed in policy)

Medicare Part B

Aetna Locoregional carcinoid tumors of the small bowel Celiac Disease: Positive serology and negative biopsyCapsule Endoscopy Celiac disease

Suspected Crohn's diseaseSuspected small intestinal bleeding

Premera BCBS Obscure GI bleed OGIB: Prior inconclusive upper AND lower gastrointestinal endoscopic studiesSuspected Crohn's disease

https://www.premera.com/stellent/groups/public/documents/medicalpolicy/cmi_003621.htm

Cigna Obscure GI bleedCapsule Endoscopy Suspected Crohn's disease

Suspected small bowel tumorCeliac disease

HealthNet Obscure GI bleedSmall bowel neoplasmSuspected Crohn's

Crohn's: Patient has diarrhea, GI bleeding, abdominal pain, weight loss, negativestool cultures and negative upper and lower endoscopy

United Healthcare GI blood loss and/or iron-deficiency anemiaSuspected or known Crohn's diseaseCeliac diseaseSuspected small bowel tumor

Celiac disease: Prior serology or GI endoscopy are not diagnosticSmall bowel tumor: Imaging studies or GI endoscopy fail to confirm a tumor

April 2012

"The information presented here is for illustrative purposes only and does not constitute reimbursement or legal advice. The medical coverage policy summary information provided by Olympus America Inc. and/or its direct or indirect (through one or more intermediaries) parent companies, affiliates, or subsidiaries (collectively, the "Olympus Group") is gathered from third party sources and is subject to change without notice. Medical coverage policy may vary widely by insurer so you should understand and comply with any specific rules that may be set by the patient's insurer. You must also understand and comply with Medicare's complex rules. It is the provider’s sole responsibility to determine medical necessity and to in turn identify which CPT codes to report and to submit accurate claims. You should always consult with your local payers regarding reimbursement matters. Under no circumstances shall the Olympus Group or its employees, consultants, agents or representatives be liable for costs, expenses, losses, claims, liabilities or other damages (whether direct, indirect, special, incidental, consequential or otherwise) that may arise from or be incurred in connection with this information or any use thereof.

http://www.cigna.com/assets/docs/health-care-professionals/coverage_positions/mm_0008_coveragepositioncriteria_wireless_capsule_endoscopy.pdf

http://apps.humana.com/tad/tad_new/Search.aspx?searchtype=beginswith&docbegin=C

Wireless Capsule Endoscopy

152.0-152.9, 197.4, 211.1, 230.7, 280.0, 280.9, 555.0-555.9, 558.1, 558.2, 558.9, 560.02, 560.03, 569.85, 569.86, 571.2, 571.5, 578.1, 578.9, 792.1

OGIB: Iron deficiency anemia, postive fecal occult blood test, or visible bleeding with no source found on original endoscopy, hematocrit < 34, failure of previous diagnostics to diagnose source of GI bleeding and GI bleeding is thought to be in the small intestineSmall Bowel Neoplasm: Diagnosis not previously confirmed by upper GI, colonoscopy, push enteroscopy, nuclear imaging or radiological procedures. Patient must be symptomatic for neoplasm (e.g. GI bleeding)

Prior authorization requirements can vary by plan. Please contact the payer to verify if your patient’s plan requires prior authorization.

Use of the Endo Capsule is limited to that which is approved by the FDA and outlined in the labeled Indications for Use of the product, and as such, not all coverage may be applicable. The labeled Indications for Use of the Endo Capsule is for the Endo Capsule to be used for visualization of the small intestine mucosa, and its Red Color Detection Function is intended to mark frames of the video suspected of containing blood.

GI blood loss and/or iron deficiency anemia: Upper endoscopy and colonoscopy are negative for source of bleeding

https://www.unitedhealthcareonline.com/ccmcontent/ProviderII/UHC/en-US/Assets/ProviderStaticFiles/ProviderStaticFilesPdf/Tools%20and%20Resources/Policies%20and%20Protocols/Medical%20Policies/Medical%20Policies/Wireless_Capsule_Endoscopy.pdf

Wireless Capsule Endoscopy as a

Diagnostic Technique in the Disorders of the Small

Bowel, Esophagus and Colon

Hereditary GI polyposis syndromes including familial adenomatous polyposis and Peutz-Jeghers syndrome

Crohn's: Without evidence of disease on conventional diagnostics tests such as SBFT and upper and lower endoscopy

211.2, 555.0, 555.1, 555.2, 555.9, 578.0, 578.1. 578.9, 759.6

Crohn's: Imaging studies and/or upper or lower GI endoscopy fail to reveal location or extent of pathology, and treatment decisions would be affected by the results of the testLynch syndrome or inherited polyposis syndromes

such as familial adenomatous polyposis and Peutz-Jeghers syndrome

http://www.aetna.com/cpb/medical/data/500_599/0588.html

152.0, 152.1, 152.2, 152.3, 152.8, 152.9, 209.00, 209.01, 209.02, 209.03, 211.2, 235.2, 280.0, 280.9, 555.0, 555.1, 555.2, 555.9, 558.1, 558.2, 558.3, 558.9, 562.02, 562.03, 569.85, 759.6, 578.0, 578.1, 578.9, 579.0, 792.1, V84.09

Wireless Capsule Endoscopy

All diagnoses: Standard endoscopic and imaging evaluations (i.e., upper and lower endoscopy) are inconclusive

152.0-152.9, 211.2, 235.2, 280.0, 280.8, 280.9, 281.9, 285.9, 555.0-555.9, 558.9, 578.1-578.9, 579.0

209.00-209.03, 209.40-209.43, 211.2, 280.0, 280.9, 285.1, 288.8, 555.0-555.9, 558.1-558.9, 578.0-578.9, 579.0, 759.6, 780.60, 780.61, 783.21, 787.91, 789.00-789.09, 790.1

Crohn's: Abdominal pain or diarrhea plus one or more signs of inflammation (fever, elevated WBC count, elevated erythrocyte sedimentation rate, or bleeding) without evidence of disease on conventional diagnostic tests, including SBFT, abdominal CT scan/CT enterography and upper and lower endoscopy

WASHINGTON

Capsule Endoscopy Payer Guidelines - CPT 91110

MAC: Noridian Administrative Services

No published LCD for capsule endoscopy. Claims will be manually reviewed.

Peutz-Jeghers syndrome and other polyposis syndromes affecting the small bowel Intestinal Bleeding: Positive fecal occult blood test or visible bleeding, upper and

lower GI endoscopies within the last 12 months that have failed to identify a bleeding source